Radiofrequency ablation of abdominal wall endometriosis

Phase 2

• Conditions: Abdominal wall endometriosis.; Endometriosis, unspecified; N80.9

• Registration Number: IRCT20220219054066N1
• Lead Sponsor: Iranian academic center for education culture and research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 10

Inclusion Criteria

Abdominal Wall Endometriosis diagnosis
no history of abdominal wall surgery over the past three months
patients without severe comorbidities, such as hypertension or diabetes
patients could tolerate 1-2 hours under general anesthesia

Exclusion Criteria

Patients with more than 1 abdominal wall endometriosis lesion
Abdominal wall endometriosis lesion volume of over 50 cc
Past surgical history of resection of abdominal wall endometriosis
Past medical history of heart failure
Allergy to cephalexin and lidocain

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score on Visual Analogue Scale. Timepoint: Pain score at the beginning of the study and 30, 90 and 180 days after treatment. Method of measurement: Visual Analogue Scale.;The volume of the lesions in abdominal Ultrasound. Timepoint: The volume of the lesions at the beginning of the study and 30, 90 and 180 days after treatment. Method of measurement: Abdominal ultrasound.